Uncategorised - European Medical Journal

Automated Insulin Systems Safe and Effective for Older Adults

New research has confirmed that automated insulin delivery (AID) systems are both safe and effective for older adults with Type 1 diabetes.

Active Lifestyle Lowers Risk of Neuropsychiatric Disease

Using a large-scale prospective design, this study analysed accelerometer data from 73,411 participants collected between 2013–2015.

How Reliable Is the New Scleroderma Skin Questionnaire?

The psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) designed to assess skin disease in patients with systemic sclerosis (SSc), has been evaluated in a new study.

Long-term MHT/HRT on Heart, Bones and Brain

In this podcast series, we focus on women’s health and the impact of menopause. Our experts explore the role and long-term impact of…

Children Drive RSV Spread Within U.S. Households

Respiratory syncytial virus (RSV) transmission in U.S. households was examined in a new study that showed young children are the primary drivers of infection, spreading the virus to adults and other household members.

Breakthrough Study Confirms Hepatitis E Vaccine Works in High-Risk Groups

A large-scale study finds that the hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic hepatitis B.

Epstein-Barr Virus as a Risk Factor for Multiple Sclerosis: New Insights

Groundbreaking research links EBV antibodies to MS via brain protein attacks. Genetic risks amplify danger, paving the way for targeted therapies.

Cancer Mortality Higher in Patients with Rheumatoid Arthritis

While patients with rheumatoid arthritis have a lower overall cancer incidence rate, they face higher post-cancer mortality.

Gut Microbiota Predicts Lung Cancer Treatment Outcomes

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer.

RSV Resistance to Nirsevimab Remains Rare in Infants

A large-scale genomic surveillance study has found that resistance to nirsevimab in infants remains rare despite widespread use.